In the context of the JAK/STAT pathway, WES allows for the discovery of rare or de novo mutations in coding regions of genes such as JAK1-3, TYK2, and STAT1-6, which may be implicated in immunodeficiencies, autoimmune syndromes, or hematological disorders. This evidence concerns the gene STAT1 and immunodeficiency disease.